Merit Medical Systems Stock Hits New 52-Week High (MMSI)

NEW YORK ( TheStreet) -- Merit Medical Systems (Nasdaq: MMSI) hit a new 52-week high Wednesday as it is currently trading at $21.36, above its previous 52-week high of $21.29 with 429,065 shares traded as of 3:52 p.m. ET. Average volume has been 200,300 shares over the past 30 days.

Merit Medical Systems has a market cap of $579.9 million and is part of the health care sector and health services industry. Shares are up 29.3% year to date as of the close of trading on Tuesday.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional and diagnostic procedures worldwide. The company's cardiology and radiology products include percutaneous coronary interventions and percutaneous peripheral interventions. The company has a P/E ratio of 47.3, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 16.6.
  • Practice your MMSI trading strategies and win cash in our stock game.

TheStreet Ratings rates Merit Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Merit Medical Systems Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

Intel Gets a Downgrade Following CEO Resignation

Intel Gets a Downgrade Following CEO Resignation

Dow Falls Sharply as Wall Street Weighs Trump's New Trade Threats

Dow Falls Sharply as Wall Street Weighs Trump's New Trade Threats

Jim Cramer: Reports of Attempted Trade Truce With China Are False

Jim Cramer: Reports of Attempted Trade Truce With China Are False

Ford and General Motors 'Notably Vulnerable' to Trade War: Moody's

Ford and General Motors 'Notably Vulnerable' to Trade War: Moody's